Haseki Training and Research Hospital

Istanbul 34096

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Relapsing Multiple Sclerosis

Studies at this site

• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS) — Running, not enrolling
• A Study of Ocrelizumab in Comparison With Interferon Beta-1a (Rebif) in Participants With Relapsing Multiple Sclerosis — Completed